• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed by Modular Medical Inc.

    2/13/23 1:24:52 PM ET
    $MODD
    Medical/Dental Instruments
    Health Care
    Get the next $MODD alert in real time by email
    SC 13G 1 b23232sc13g.htm

     

    CUSIP No. 60785L108 Page 1 of 6
     

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
     
    SCHEDULE 13G
     
    Under the Securities Exchange Act of 1934
     
     
    Modular Medical, Inc.
    (Name of Issuer)
     
    Common stock, par value $0.001 per share
    (Title of Class of Securities)
     
    60785L108
    (CUSIP Number)
     
    December 31, 2022
    (Date of Event Which Requires Filing of this Statement)

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     

    ☒Rule 13d-1(b)
    ☐Rule 13d-1(c)
    ☐Rule 13d-1(d)

     

    *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

     

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

      
     

    CUSIP No. 60785L108 Page 2 of 6

     

    1.

    Names of Reporting Person

     

    I.R.S. Identification Nos. of Above Persons (entities only)

     

    Sio Capital Management, LLC

     

    20-4586565

    2.

    Check the Appropriate Box if a Member of a Group

     

     

    (a) ☐

    (b) ☐

    3.

    SEC Use Only

     

     
    4.

    Citizenship or Place of Organization

     

    Delaware

    Number of Shares Beneficially

    Owned by Each Reporting

    Person With1

    5.

    Sole Voting Power

     

    -0-
    6.

    Shared Voting Power

     

    1,091,479
    7.

    Sole Dispositive Power

     

    -0-
    8.

    Shared Dispositive Power

     

    1,091,479

    9.

    Aggregate Amount Beneficially Owned by Each Reporting Person

     

    1,091,479
    10.

    Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares

     

     

    ☐

    11.

    Percent of Class Represented by Amount in Row (9)

     

    9.99%2
    12. Type of Reporting Person IA
               

     

    _____________________

     

    1 As of December 31, 2022, Sio Capital Management, LLC beneficially owned 689,352 shares of Common Stock with shared voting power and shared dispositive power. Subject to the ownership blocker described below, Sio Capital Management, LLC may also be deemed to beneficially own 1,348,314 shares of Common Stock issuable upon exercise of certain Pre-Funded Warrants and 1,438,202 shares of Common Stock issuable upon exercise of certain Purchase Warrants. Pursuant to the terms of the Pre-Funded Warrants and Purchase Warrants, a holder (together with its affiliates) does not have the right to exercise any portion of the Pre-Funded Warrants and Purchase Warrants held by such holder, to the extent the holder would own more than 9.99% of the Issuer’s outstanding Common Stock immediately after exercise. The holder, however, may decrease or increase the limitation of ownership at a holder’s election upon 61 days’ notice. The 1,091,479 shares of Common Stock reported as beneficially owned by Sio Capital Management, LLC in this Schedule 13G represents 9.99% of the outstanding shares of Common Stock (see footnote (2) below).

    2 Based on 10,925,723 shares of common stock outstanding as of November 14, 2022, as reported in the Issuer’s Form 10-Q filed with the SEC on November 14, 2022 as well as the ownership blocker described in footnote (1) above.

     

      
     

    CUSIP No. 60785L108 Page 3 of 6

     

     

    Schedule 13G

     

    Item 1(a).Name of Issuer:

     

      Modular Medical, Inc.

     

    Item 1(b).Address of Issuer’s Principal Executive Offices:

     

     

    16772 W. Bernardo Drive

    San Diego, CA 92127

     

    Item 2(a).Name of Persons Filing:

     

      This Statement is filed on behalf of Sio Capital Management, LLC (the “Reporting Person” or “Sio”)
       
      Sio is a registered investment adviser to certain affiliated funds that directly hold the shares of Common Stock to which this statement relates for the benefit of their respective investors, and in such capacity Sio has voting and dispositive power over such shares.

     

    Item 2(b).Address of Principal Business Office:

     

     

    600 Third Avenue, 2nd Floor

    New York, New York 10016

     

    Item 2(c).Citizenship:

     

      Sio is a Delaware limited liability company.   

     

    Item 2(d).Title of Class of Securities:

     

      Common stock, par value $0.001

     

    Item 2(e).CUSIP Number:

     

      60785L108

     

     

      
     

    CUSIP No. 60785L108 Page 4 of 6

     

     

    Item 3. If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

     

    (a) ☐ Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).
    (b) ☐ Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 73c).
    (c) ☐ Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C.78c).
    (d) ☐ Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
    (e) ☒ An investment adviser in accordance with §13d-1(b)(1)(ii)(E).
    (f) ☐ An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F).
    (g) ☐ A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G).
    (h) ☐ A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813).
    (i) ☐ A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3).
    (j) ☐ Group, in accordance with §240.13d-1(b)(1)(ii)(J).

     

    ☐ If this statement is filed pursuant to §240.13d-1(c), check this box.

     

     

     

    Item 4.Ownership.

     

    (a) through (c):

     

    The information set forth in Items 5 through 9 and 11 of the cover pages to this Schedule 13G is incorporated herein by reference.3

     

     

     

    Item 5.Ownership of Five Percent or Less of a Class.

     

     

    Not Applicable.

     

    _____________________

     

    3 Sio and Sio GP, LLC (the “GP”) act as investment advisor and general partner, respectively, to various clients that are the record owners of the Common Stock reported on this Schedule 13G. Because Sio’s investment discretion with respect to such clients is subject to oversight by the GP, the GP may be deemed to be the beneficial owner of the Common Stock of the Issuer owned by such clients. In addition, both Sio and the GP are controlled by Michael Castor. As such, he may be deemed to control the voting and dispositive decisions with respect to, and therefore be the beneficial owner of, the shares of Common Stock reported on this Schedule 13G. Neither the filing of this Schedule 13G nor any of its contents shall be deemed to constitute an admission by the GP or Michael Castor that such person is the beneficial owner of any of the equity securities referred to herein for purposes of Section 13(d) of the Exchange Act, or for any other purpose, and such beneficial ownership is expressly disclaimed.

     

      
     

    CUSIP No. 60785L108 Page 5 of 6

     

    Item 6.Ownership of More than Five Percent on Behalf of Another Person.

     

      Various advisory clients of the Reporting Person have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the Common Stock of Modular Medical, Inc. in their accounts with the Reporting Person. See Item 2(a) above.

     

    Item 7.Identification and Classification of the Subsidiary Which Acquired the Security Being Reported By the Parent Holding Company.

     

      Not Applicable.

      

    Item 8.Identification and Classification of Members of the Group.

     

      Not Applicable.

     

    Item 9.Notice of Dissolution of a Group.

     

      Not Applicable.

     

    Item 10.Certification.

     

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to herein were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the Issuer and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

     

      
     

    CUSIP No. 60785L108 Page 6 of 6

     

    SIGNATURE

     

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

    Dated: February 13, 2023

     

      SIO CAPITAL MANAGEMENT, LLC  
         
         
        By: /s/ Jin W. Lee  
             
        Name:  Jin W. Lee  
        Title: Chief Compliance Officer  

     

     

     

     

     

    Get the next $MODD alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $MODD

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $MODD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Director Goldberg Jeff D

    4 - Modular Medical, Inc. (0001074871) (Issuer)

    10/3/25 6:21:17 AM ET
    $MODD
    Medical/Dental Instruments
    Health Care

    SEC Form 4 filed by Director Vos Ellen O'Connor

    4 - Modular Medical, Inc. (0001074871) (Issuer)

    10/2/25 8:34:55 PM ET
    $MODD
    Medical/Dental Instruments
    Health Care

    SEC Form 4 filed by Director Sheibley Philip Brent

    4 - Modular Medical, Inc. (0001074871) (Issuer)

    10/2/25 8:33:46 PM ET
    $MODD
    Medical/Dental Instruments
    Health Care

    $MODD
    SEC Filings

    View All

    Modular Medical Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

    8-K - Modular Medical, Inc. (0001074871) (Filer)

    9/23/25 8:30:42 AM ET
    $MODD
    Medical/Dental Instruments
    Health Care

    SEC Form EFFECT filed by Modular Medical Inc.

    EFFECT - Modular Medical, Inc. (0001074871) (Filer)

    8/20/25 12:15:02 AM ET
    $MODD
    Medical/Dental Instruments
    Health Care

    SEC Form POS AM filed by Modular Medical Inc.

    POS AM - Modular Medical, Inc. (0001074871) (Filer)

    8/13/25 5:29:22 PM ET
    $MODD
    Medical/Dental Instruments
    Health Care

    $MODD
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Manchester Management Co Llc bought $1,299,997 worth of shares (677,082 units at $1.92) (SEC Form 4)

    4 - Modular Medical, Inc. (0001074871) (Issuer)

    3/24/25 9:34:00 PM ET
    $MODD
    Medical/Dental Instruments
    Health Care

    Director by Deputization Manchester Management Co Llc bought $35,236 worth of shares (21,000 units at $1.68) (SEC Form 4)

    4 - Modular Medical, Inc. (0001074871) (Issuer)

    12/4/24 6:05:34 PM ET
    $MODD
    Medical/Dental Instruments
    Health Care

    Director by Deputization Manchester Management Co Llc bought $168,950 worth of shares (100,000 units at $1.69) (SEC Form 4)

    4 - Modular Medical, Inc. (0001074871) (Issuer)

    11/29/24 10:00:09 AM ET
    $MODD
    Medical/Dental Instruments
    Health Care

    $MODD
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Modular Medical Announces Licensing and Partnership Agreement With Nudge BG

    -Modular Medical will collaborate with Nudge BG to bring to market an adaptive full closed loop Automated Insulin Delivery system that does not require mealtime announcements-Effort will be led be Nudge BG founder and noted AID expert, Lane Desborough SAN DIEGO, CALIFORNIA / ACCESSWIRE / December 19, 2024 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), an insulin delivery technology company with the first FDA-cleared patch pump designed specifically to meet the needs of "almost-pumpers" with its user-friendly and affordable design, announced a licensing and partnership agreement with Nudge BG."We are very excited to partner with Modular Medical to bring the next g

    12/19/24 4:01:00 PM ET
    $MODD
    Medical/Dental Instruments
    Health Care

    Modular Medical Announces Conference Call to Provide Business Update

    SAN DIEGO, CA / ACCESSWIRE / December 3, 2024 / Modular Medical, Inc. (the "Company" or "Modular Medical") (NASDAQ:MODD), an insulin delivery technology company with the first FDA-cleared patch pump designed specifically to target all adult "almost-pumpers" with its user-friendly and affordable design, today announced it will hold a conference call and webcast on Thursday, December 5, 2024, at 10:00 a.m. Eastern Time to provide a business update.Conference Call and Webcast InformationDate: December 5, 2024Time: 10:00 a.m. Eastern Time (7:00 a.m. Pacific Time)Conference Call Number: 1-888-506-0062International Call Number: +1-973-528-0011Passcode: 494842Webcast: CLICK HEREFor those unable to

    12/3/24 8:00:00 AM ET
    $MODD
    Medical/Dental Instruments
    Health Care

    Modular Medical Announces Pricing of $8.2 Million Public Offering

    SAN DIEGO, CA / ACCESSWIRE / November 21, 2024 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), an insulin delivery technology company with the first FDA-cleared patch pump designed specifically to target all adult "almost-pumpers" with its user-friendly and affordable design, today announced that it has priced an underwritten public offering (the "offering") of 5,450,573 shares of its common stock. The offering was led by existing institutional investors, including Manchester Explorer, L.P., which is the largest shareholder of the Company and is managed by Jeb Besser, Modular Medical's Chief Executive Officer. The shares of common stock are being sold at a price t

    11/21/24 9:15:00 PM ET
    $MODD
    Medical/Dental Instruments
    Health Care

    $MODD
    Financials

    Live finance-specific insights

    View All

    Modular Medical Announces Conference Call to Provide Business Update

    SAN DIEGO, CA / ACCESSWIRE / December 3, 2024 / Modular Medical, Inc. (the "Company" or "Modular Medical") (NASDAQ:MODD), an insulin delivery technology company with the first FDA-cleared patch pump designed specifically to target all adult "almost-pumpers" with its user-friendly and affordable design, today announced it will hold a conference call and webcast on Thursday, December 5, 2024, at 10:00 a.m. Eastern Time to provide a business update.Conference Call and Webcast InformationDate: December 5, 2024Time: 10:00 a.m. Eastern Time (7:00 a.m. Pacific Time)Conference Call Number: 1-888-506-0062International Call Number: +1-973-528-0011Passcode: 494842Webcast: CLICK HEREFor those unable to

    12/3/24 8:00:00 AM ET
    $MODD
    Medical/Dental Instruments
    Health Care

    Modular Medical Announces Conference Call to Discuss FDA Clearance of the MODD1 Insulin Pump

    SAN DIEGO, CA / ACCESSWIRE / September 4, 2024 / Modular Medical, Inc. (the "Company" or "Modular Medical") (NASDAQ:MODD), an insulin delivery system technology company preparing to launch a market expansion product with a more accessible, easier to prescribe, and easier to pay for and live with technology, today announced it will hold a conference call and webcast tomorrow, Thursday, September 5, 2024, at 8:30 a.m. Eastern Time to discuss the U. S. Food and Drug Administration ("FDA") clearance of its MODD1 pump, as well as next steps and milestones.Conference Call and Webcast InformationDate: September 5, 2024Time: 8:30 a.m. Eastern Time (5:30 a.m. Pacific Time)Conference Call Number: 1-88

    9/4/24 6:57:00 PM ET
    $MODD
    Medical/Dental Instruments
    Health Care

    Modular Medical Announces FDA Clearance of the MODD1 Insulin Pump

    MODD1 is a patch pump for ALL adults with Type 1 and Type 2 diabetesDesigned to be simpler and more affordable to expand access to diabetes technology for previously underserved communitiesCommercial availability expected in early 2025 SAN DIEGO, CA / ACCESSWIRE / September 4, 2024 / Modular Medical, Inc. (the "Company" or "Modular Medical") (NASDAQ:MODD), an insulin delivery system technology company preparing to launch a market expansion product with a more accessible, easier to prescribe, and easier to pay for and live with technology, today announced it has received U. S. Food and Drug Administration ("FDA") clearance to market and sell its MODD1 pump in the United States. With its comme

    9/4/24 4:30:00 PM ET
    $MODD
    Medical/Dental Instruments
    Health Care

    $MODD
    Leadership Updates

    Live Leadership Updates

    View All

    Modular Medical Announces Addition to the Russell Microcap(R) Index

    SAN DIEGO, CA / ACCESSWIRE / June 3, 2024 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical"), a development-stage, insulin delivery technology company seeking to launch the next generation of user-friendly and affordable insulin pump technology, today announced that it is set to join the Russell Microcap Index at the conclusion of the 2024 Russell indexes annual reconstitution, effective when the U.S. market opens on July 1, 2024.Membership in the Russell Microcap Index, which remains in place for one year, means automatic inclusion in the appropriate growth and value style indexes. FTSE Russell determines membership for its Russell indexes primarily by objective, market-capitalizatio

    6/3/24 8:00:00 AM ET
    $MODD
    Medical/Dental Instruments
    Health Care

    Modular Medical Announces Diabetes Industry Veteran Duane DeSisto Will Join the Board of Directors

    SAN DIEGO, CA / ACCESSWIRE / July 6, 2023 / Modular Medical, Inc. (the "Company" or "Modular Medical") (NASDAQ:MODD), a development stage insulin delivery technology company seeking to launch the next generation of easy to use and affordable insulin pump technology, today announced the appointment of medical device industry leader Duane DeSisto to its board of directors. Mr. DeSisto was previously President, CEO and Director of Insulet Corporation, developers of the groundbreaking OmniPod Insulin Management System, before retiring in 2014."Duane brings more than 25 years of experience in the medical device industry and is a visionary business leader credited with the launch and transformatio

    7/6/23 8:30:00 AM ET
    $MODD
    Medical/Dental Instruments
    Health Care

    Modular Medical Appoints Kevin Schmid as Chief Operating Officer

    Schmid brings 40 years of experience in medical devices for drug delivery and diabetes management and a background in high-volume manufacturingSAN DIEGO, CA / ACCESSWIRE / July 26, 2022 / Modular Medical, Inc. (the "Company" or "Modular Medical")(NASDAQ:MODD) today announced that it has appointed industry veteran Kevin Schmid as its Chief Operating Officer. Mr. Schmid brings extensive operations and business development leadership experience in diabetes and drug delivery. As Vice President of Operations and Business Development at Insulet Corporation, he was instrumental in the development, manufacturing, and commercialization of wearable smart drug delivery pumps such as the Omnipod Diabete

    7/26/22 8:15:00 AM ET
    $MODD
    Medical/Dental Instruments
    Health Care

    $MODD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Modular Medical Inc.

    SC 13D/A - Modular Medical, Inc. (0001074871) (Subject)

    11/25/24 7:18:33 PM ET
    $MODD
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G filed by Modular Medical Inc.

    SC 13G - Modular Medical, Inc. (0001074871) (Subject)

    3/1/24 3:48:41 PM ET
    $MODD
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13D/A filed by Modular Medical Inc. (Amendment)

    SC 13D/A - Modular Medical, Inc. (0001074871) (Subject)

    2/21/24 5:20:18 PM ET
    $MODD
    Medical/Dental Instruments
    Health Care